Stroma and Immune cell infiltration are increased in pancreatic carcinoma after neoadjuvant therapy

Objectives The role of pancreatic tumor stroma and inflammation in neoadjuvant therapy efficacy remains controversial. The aim of this study was to evaluate the role of pancreatic ductal adenocarcinoma (PDAC) stroma and infiltrating immune cells after neoadjuvant therapy

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Li Xie, Leizhou Xia, Ulla Klaiber, Milena Sachsenmaier, Oliver Strobel, Markus W. B üchler, Franco Fortunato, Thilo Hackert Tags: 8. Pancreatic Cancer I Source Type: research